// App-Quantinova.ai

: Late Breaking Abstract - Dose responses for topical efficacy and systemic activity, dose equivalence and relative therapeutic index for fluticasone furoate (FF), fluticasone propionate (FP) and budesonide (BUD) in asthmatic subjects

Researchers

Presenter

  • Peter Daley-Yates

Principal Investigators

  • Noushin Brealey

  • Bharath Kumar

  • Sebin Thomas

  • Daren Austin

  • Shaila Shabbir

  • Tim Harrison

  • Dave Singh

  • Neil Barnes

Medical Centers

  • Clinical Pharmacology & Experimental Medicine, GlaxoSmithKline, Uxbridge, United Kingdom

  • Biostatistics and Programming, GlaxoSmithKline, Bangalore, India

  • Medicines Research Centre, GlaxoSmithKline, Stevenage, United Kingdom

  • Nottingham NIHR Biomedical Research Centre, Nottingham City Hospital, University of Nottingham, Nottingham, United Kingdom

  • Medicines Evaluation Unit, University of Manchester, Manchester, United Kingdom,

  • Global Medical Franchise, GSK House, Brentford, United Kingdom,

Locations

  • United Kingdom

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Asthma

  • Gastric antral vascular ectasia

Biomarkers

  • Cortisol

Drug/Treatment

  • Fluticasone propionate

  • Fluticasone furoate

  • Glucocorticoid

  • Fluticasone

  • Budesonide

  • Adenosine

  • Adenosine Intravenous

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Cross Over

Phase

  • NA

Study Id's

  • NCT02991859

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved